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Summary We studied peripheral blood mononuclear c6lls from 50 patients with active B- and T-cell non-
Hodgkin's lymphoma by DNA hybridisation. Nineteen patients (38%) had circulating clones of cells detected
by immunoglobulin gene rearrangement (17 patients) or T-cell receptor gene rearrangement (2 patients) with
J,, and J¾2 probes. Lymphoma tissue and peripheral blood were studied simultaneously in 22 patients, 9 of
which had a circulating clone of cells in peripheral blood. In 7 patients the gene rearrangement in lymphoma
tissue and peripheral blood mononuclear cells was identical. However, in 2 patients both heavy chain and
light chain gene rearrangements were different in tissue and peripheral blood. The incidence of peripheral
blood involvement was commonest in advanced CSIII & IV disease (54%) compared to CSI & II disease
(18%) (P<0.05), and in low grade (45%) compared to intermediate and high grade lymphoma (31%)
(difference not statistically significant). Only 4 patients had definite lymphoma cells seen on peripheral blood
smear. The presence of circulating lymphoma cells correlated with conventional assessment of bone marrow
involvement although circulating clones were detected in 30% (12/40) of patients with apparently normal
bone marrow.
Lymphoma cells have been detected in peripheral blood by
routine morphological examination of the blood smear
(Come et al., 1980; Dick et al., 1974; Foucar et al., 1982;
Garrett et al., 1979; McKenna et al., 1975). Their presence in
B-cell lymphoma has also been implied with k and . light
chain staining and the demonstration of abnormal k/. ratio
(Sobol et al., 1985; Johnson et al., 1985), clonal excess
(Ligler et al., 1980; Weinberg et al., 1984) or by cytofluori-
metric studies (Smith et al., 1984). With the advent of clonal
analysis by immunoglobulin (Ig) and T-cell receptor (TCR)
gene rearrangement studies of B- and T-ccll lymphomas
(Arnold et al., 1983; Cleary et al., 1984; Bertness et al., 1985;
O'Connor et al., 1985), it has become possible to detect
clonal rearrangement with up to I % sensitivity (Arnold et al.
1983). This allows for the detection of clones of cells in
peripheral blood and has already been successfully applied to
patients with low grade B-cell lymphoma who have a high
frequency of bone marrow and peripheral blood involvement
(Hu et al., 1985).
We have set out to establish whether the clones of cells in
peripheral blood represent circulating lymphoma cells and to
assesses the frequency of peripheral blood involvement in all
histological types and stages of non-Hodgkin's lymphoma
(NHL). Where possible we also compared the assessment of
bone marrow involvement by conventional and DNA
hybridization techniques.
Patients and methods
Patients
We studied 32 consecutive untreated patients with non-
Hodgkin's lymphoma (NHL) referred to the Lymphoma
Unit at the Royal Marsden Hospital and 18 patients with
recurrent lymphoma undergoing tissue biopsy. All patients
had full staging investigations which included full blood
count, differential white count, routine biochemistry, bone
marrow aspirate and trephine biopsy, chest X-ray and CT
scan of chest and abdomen. Selected patients had bipedal
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lymphography. Their clinical stage was assigned according to
Ann Arbor classification (Carbone et al., 1971). The
histology was reviewed by a single pathologist (JPS) and
classified according to the Working Formulation (The Non-
Hodgkin's Lymphoma Pathologic Classification Project
(1982)). In 5 patients classification was based on the
referring hospital's report. Peripheral blood cytology was
examined independently of the DNA analysis by a single
haematologist (JT). Peripheral blood involvement by
lymphoma was defined as the presence of more than four
cells resembling lymphoma cells on microscopic examination
of 15 high power fields (x 400). Detection of 2-4 abnormal
cells was defined as 'suspicious of involvement'. DNA
hybridisation of peripheral blood mononucleur cells was
performed on all 50 specimens. We also examined the DNA
from bone marrow aspirates of 12 and from tissue biopsy of
22 of these patients. Peripheral blood was also obtained
from 15 controls - 7 patients with Hodgkin's disease, 3
normal volunteers, 2 patients with chronic myeloid
leukaemia (CML) in chronic phase and 3 with other con-
ditions (1 undifferentiated tumour and 2 reactive lymphaden-
opathy). In addition we studied 9 control lymph node
biopsies from 6 patients with Hodgkin's disease at presen-
tation and 3 with other conditions (as above).
Methods
Forty ml of venous blood anticoagulated with preservative-
free heparin were separated on a Ficoll/Isopaque density
gradient to obtain a mononucleur cell fraction. Cells were
washed twice in buffered tissue culture medium and frozen
until further analysis. Where available, bone marrow aspirate
was treated in a similar manner. Tissue biopsy material was
frozen and kept at -90 C. Before digestion the tissue was
disrupted by grinding in liquid nitrogen.
DNA was prepared by standard methods (Ford et al.,
1983). DNA (IOpg) was digested with restriction enzymes-
EcoRI, XbaI and in selected cases with HindII, EcoRV or
BanmHI. Fragments were separated by electrophoresis on
0.7% agarose gel, transferred onto nitrocellulose filter
(Southern, 1975) and hybridized with immunogiobulin gene
or T-cell receptor gene probes. These were radio-labelled
with, 32P-CTP by random primer extension method. We
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initially used J. DNA probe (Bgl If - Bgl II fragment
excised from CH28-6; Ravetch et al., 1981) and J.2 probe
(4.2kb EcoRI restriction fragment of J,2 region) kindly
provided by Dr P. Leder and Dr B. Toyonaga. BamHI
digests were hybridized with CK probe.
DNA from all specimens was initially digested with EcoRI
and XbaI restriction enzymes and hybridised with J,, and J.2
probes. If rearrangement was detected with only one enzyme,
DNA was further digested with either HindlII or EcoRV
restriction enzymes and hybridised with JH or JP2 respec-
tively. A circulating clone of cells was considered to be
present if one or two rearranged bands in addition to
germline band were present on at least two separate enzyme
digests. One patient had rearrangement detected on CK
probing of BamHI digest alone.
Results
The clinical stage and histological grade of 32 untreated and
18 relapsed patients with non-Hodgkin's lymphoma are
shown in Table I. Twenty-four patients had low grade
(A =3, B = 15, C=6, 1 uncertain), and 25 intermediate and
high grade lymphomas (D=1, E=3, F=4, G=O0, H=4,
Table I Fifty patients with non-Hodgkin's lymphoma (The Royal
Marsden Hospital, 1986)
Previously untreated Recurrent disease
Histology' CSI & II CSII & IV CSI & ilb CSIJI & IVb
Low grade 5 12 3 4
Intermediate and
high gradec 10 5 4 7
aClassified according to Working Formulation; bClinical stage at
the time of relapse; cIncludes 1 patient with aggressive cutaneous T-
cell lymphoma.
I= 1, 1 uncertain). One patient with aggressive cutaneous T-
cell lymphoma was included in the latter category. On
immunohistochemical and in some cases on additional gene
rearrangement criteria 46 patients had B- and 4 T-cell
lymphoma. One patient had coexistent follicular small
cleaved cell lymphoma with cutaneous T-cell lymphoma. The
mean age (range; s.d.) at the time of study was 53 (19-73;
14.5) years. Nineteen of 50 patients studied (38%) had Ig or
TCR gene rearrangement detected in peripheral blood. Two
had T-cell and 17 B-cell lymphoma. Examples are shown in
Figure 1. Peripheral blood from 15 control subjects was
normal without detectable rearrangement.
Gene rearrangement in peripheral blood and lymphoma tissue
We were able to study biopsy tissue and peripheral blood
simultaneously in 22 patients. All 22 biopsy specimens
showed gene rearrangement; 20 on JH and 4 on JP2 probing.
One patient with T-cell lymphoblastic lymphoma on
immunohistochemical criteria had both TCR gene and Ig
gene rearrangement. The latter was only detected by heavy
chain probing (JH) with light chain gene (CK and cA) in
germline configuration (data not shown). One patient had
coexistent B- and T-cell lymphoma (see above).
We detected gene rearrangement in mononuclear cells
from peripheral blood from 9 of these patients. In 7 the
rearrangement in peripheral blood and tissue biopsy material
was identical on JH (5 patients) or JB2 (2 patients) probing
(e.g. Figure 2). Two patients had different rearrangement in
the 2 specimens. One patient with recurrent diffuse large cell
lymphoma confined to single nodal site (Figure 3) and one
with extensive recurrence of diffuse small cleaved cell
lymphoma which initially presented in a nodular form. On
further analysis of light chain gene with BamHI digestion
and C, probing we also detected different rearrangement in
lymphoma tissue and peripheral blood in both patients.
Peripheral blood
JH probe
X H
Pts. 28 (GY)
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Figure 1 Examples of Southern blot analyses of DNA extracted from mononuclear cell layer of peripheral blood from 3
patients with active non-Hodgkin's lymphoma showing immunoglobulin gene rearrangement. Each DNA was digested with at
least 2 enzymes and hybridised with the JH probe. Open triangle denotes the position of germline band and closed triangle shows
position offaint rearranged band(s). (.. represents artefacts due to partial digestion or contamination.)
H
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Frequency ofperipheral blood involvement
Of 19 patients with detectable clonal rearrangement in
peripheral blood seven had recurrent disease and 12 were
untreated. Fifteen had Ig and 2 TCR gene rearrangement in
association with B- and T-cell lymphomas respectively.
The distribution of peripheral blood involvement in
relation to stage and histology is shown in Table II. It was
more common in advanced compared to localised disease
(CSI & II vs. CSIII & IV; 54% vs. 18%) and in low grade
compared to high and intermediate grade lymphoma (46%
vs. 31%) although the latter did not reach statistical signifi-
cance. The difference between early and advanced disease
was maintained when the extent of disease was corrected for
histological grade.
Gene rearrangement and conventional assessment ofperipheral
blood
Of 19 patients with Ig and TCR gene rearrangement detect-
able in peripheral blood only 4 had suspected lymphoma
cells on routine peripheral blood film stained with May-
Grunwald-Giemsa stain (Table III). In 1 patient with a
positive smear there was no detectable abnormality on DNA
hybridisation. Three of 9 patients with suspicious peripheral
blood smear and 12 of 35 with apparently normal smear had
rearrangement detected in peripheral mononuclear cells by
DNA hybridisation. The total white count and mononuclear
cell counts did not differ significantly between patients with
and without rearrangement (Figure 4).
Bone marrow involvement
All patients had conventional bone marrow assessment by
aspirate and trephine biopsy. Bone marrow was considered
to be involved by lymphoma when the histology and/or
cytology were abnormal. The frequency of peripheral blood
involvement in relation to bone marrow cytology and
histology is shown in Table IV. Seventy per cent of patients
with bone marrow disease had clonal rearrangement detected
in circulating mononuclear cell fraction compared to 30% of
patients with normal bone marrow. The incidence was not
related to the histological grade of lymphoma.
DNA analysis was performed on bone marrow aspirate
from 12 patients. Four had detectable rearrangement which
in 3 cases was identical to peripheral blood (example in
Figure 1). Comparison of DNA hybridisation and con-
ventional bone marrow assessment (Table V) shows a false
negative rate for histology of 20% (2/10).
Discussion
As shown previously (Hu et al., 1985; Berliner et al., 1986),
we were able to demonstrate the presence of circulating
clones of mononuclear cells in patients with non-Hodgkin's
lymphoma as specific immunoglobulin or T-cell receptor
gene rearrangements. Seven patients had identical gene re-
arrangement in peripheral blood and lymphoma tissue,
suggesting that circulating clones of cells represent
lymphoma cells. In 2 patients, both with recurrent disease,
the pattern of heavy and light chain rearrangement differed
between peripheral blood and lymphoma tissue and this
could be ascribed to biclonality (Sklar et al., 1984). Preser-
vation of specific translocation detected by bcl-2 probe (pFl-
2; Cleary et al., 1985) and identical VDJ joining sequences in
cases described by Sklar et al. (1984) suggest that the
apparent biclonality may also be due to somatic mutation
(Cleary, personal communication). In our cases this would
have to be explained by two mutations.
Permanent cell lines of B-cell lineage can undergo further
rearrangement by exchange with an upstream V segment
(Reth et al., 1986; Kleinfield et al., 1986). Although such
alterations have not been demonstrated in vivo they may also
be a cause of apparent biclonality based on Ig gene re-
arrangement studies alone.
Table II Frequency of detection of Ig and TCR gene rearrangement
in peripheral blood in 50 patients with NHL (The Royal Marsden
Hospital, 1986)
CsI & II CSIII & IV All stages
Number Number Number
Histologya of of of
of lymphoma patientSb % patients % patients %
Low grade 2/8 25 9/16 56 11/24 46
Intermediate and
high grade 2/14 14 6/12 50 8/26 31
All histologies 4/22 18 15/28 54 19/50 38
aGrades according to Working Formulation; bExpressed as a
number of patients with detectable rearrangement/number of
patients tested.
Table III Detection of circulating lymphoma cells: Comparison of
conventional cytology with DNA analysis
Gene rearrangement in
peripheral blood mononuclear cells
Cytology ofperipheral
blood smear Detected Not detected Total
Positive 4 1 5
Suspicious 3 6 9
Negative 12 23 35
Not available - 1
Total 19 31 50
Table IV Frequency of detection of circulating lymphoma cells
in relation to conventional bone marrow involvement (The Royal
Marsden Hospital, 1986)
Bone marrow
Involved' Not involved'
Histology Number of Number of
oflymphoma patientsb % patients %
Low grade 6/7 86 5/17 29
Intermediate and
high grade 1/3 33 7/23 30
All histologies 7/10 70 12/40 30
aAssessed by cytology of bone marrow aspirate and histology
of trephine biopsy; bExpressed as number of patients with
detectable rearrangement in peripheral blood/number of patients
studied.
Table V Bone marrow involvement by lymphoma: Comparison
of cytology and histology with DNA analysis in 12 patients (The
Royal Marsden Hospital, 1986)
Conventional histology and cytology
ofbone marrowa
Gene rearrangement
in bone marrow* Involved Not involved
Detected 2 2
Not detected 0 8
aNumber ofpatients.150 M. BRADA et al.
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Figure 2 Autoradiographs of DNA analyses obtained from lymphoma tissue (In), peripheral blood mononuclear cells (pb) and
mononuclear cells from bone marrow (bm). The pattern of immunoglobulin gene rearrangement was obtained by digestion with
two separate enzymes (EcoRI and XbaI) and hybridisation of Southern blots with JH probe. Open triangles indicate the position of
germline band and closed triangles the position of rearranged bands.
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Figure 3 Analysis of immunoglobulin gene rearrangements in lymphoma tissue (ln) and peripheral blood mononucleal cells (pb)
from patient with recurrent diffuse large cell lymphoma. (a) Autoradiograph of Southern blot analysis of EcoRl and XhaI DNA
digests probed with JI, probe. (b) BamHI digest probed with cK probe. [Open triangle indicates the position of germline band and
closed triangle the position of rearranged band(s).]CIRCULATING LYMPHOMA CELLS 151
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Figure 4 Total white count (a) and mononuclear cell count (b)
in patients with and without circulating lymphoma cells as
defined by immunoglobulin or T-cell receptor gene rearrange-
ment in peripheral blood. Filled symbols represent patients with
lymphoma cells seen on peripheral blood smear. Numbers in
brackets indicate the individual cell counts outside the range in
figure.
Hu et al. (1985) reported identical Ig gene rearrangement
in lymphoma tissue and circulating cells in 7 patients with
follicular B-cell lymphoma. Identical light chains on circu-
lating mononuclear cells and lymphoma tissue also suggest
that the circulating clonal population represents lymphoma
cells (Smith ct al., 1984).
We detected circulating clones of cells in 19/50 (38%)
patients with active lymphoma and the incidence of blood
involvement was related to the extent of disease and possibly
to histological grade (Table II).
Lymphoma cells have been detected on peripheral blood
smear in 8-20% of patients with NHL (Come et al., 1980;
Dick et al., 1974; Foucar et al., 1982; McKenna et al., 1975;
Morra et al., 1985). With the use of immunocytochemical
staining of light chains with anti k and A. antibodies the
presence of circulating lymphoma cells has been implied in a
larger proportion of NHL patients. Abnormal k/2 ratio or
Iclonal excess' suggested lymphoma cells in peripheral blood
of 36-55% of patients (Garrett et al., 1979; Johnson et al.,
1985: igler et al.. 1980; Lindemalm et al., 1985; Sobol et al.,
1985). With cytofluorimetric analysis of k and A stained
mononuclear cell populations the peripheral blood involve-
ment has been reported in up to 78% of the patients studied
(Smith et al., 1984). Although, to some extent, these results
reflect increased sensitivity of the more sophisticated tech-
niques (Smith et al., 1984; Berliner et al., 1986), they are also
dependent on patient selection particularly as all studies had
shown correlation with stage and histological grade similar
to our findings. The presence of circulating tumour cells,
which is conventionally considered a feature of high grade
malignancy is commoner in the more benign lymphomas of
low grade. It may reflect what Jaffe describes as 'benign'
nature of low grade lymphoma (Jaffe, 1983), where tumour
cells may retain some of the recirculation properties of
normal lymphocytes (de Sousa, 1981).
The site of origin of circulating lymphoma cells is,
however, not certain. The majority of patients with these
cells have morphological bone marrow involvement; only
30% with normal bone narrow have peripheral blood
lymphoma cells. As the false negative rate of 20% for
conventional bone marrow cytology and histology is similar,
circulating lymphoma cells may reflect bone marrow
involvement. This view is supported by studies where
abnormal peripheral blood cytology was detected only in
association with a positive bone marrow although Smith et
al. (1984), using cytofluorimetry, detected circulating clones
of cells in 80% of patients with normal bone marrow.
The possibility of peripheral lymphoma cells originating in
lymphoma tissue cannot be excluded particularly if bone
marrow is considered a transient stop in the recirculation of
lymphocytes or if we adhere to the traditional view of spread
from primary to metastatic sites via the blood stream. To
answer the question of tumour cell origin it will be necessary
to perform longitudinal studies, particularly in patients
receiving only local therapy.
Clinical relevance and conclusion
It remains to be shown if the detection of lymphoma cells in
peripheral blood with such high sensitivity is of prognostic
or therapeutic importance. Our findings support the view of
low grade lymphoma as a systemic disease (Jaffe, 1983). The
detection of lymphoma cells in blood is unlikely to alter
current treatment strategies except in early disease where
local radiotherapy is the treatment of choice (Paryani et al.,
1983; Sutcliffe et al., 1985). Our findings of 25% of
peripheral blood involvement in CSI and II NHL may
indicate the source of failure in a proportion of these
patients. If peripheral blood lymphoma cells represent bone
marrow disease we may also speculate that in low grade
lymphoma their detection will be of no prognostic
significance (Bartl et al., 1982; Lindemalm et al., 1985;
Bennett et al., 1986).
Similar considerations apply to intermediate and high
grade lymphomas although bone marrow involvement in
these tumours is considered a poor prognostic factor (Fisher
et al., 1981; Gams et al., 1985; Steward et al., 1984; Bennett
et al., 1986). With the increasingly successful use of chemo-
therapy in early-stage disease (Miller et al., 1983; Cabanillas,
1983) there is less need for exact delineation of tumour sites.
However, if we consider local radiotherapy a less toxic
treatment, the detection of circulating lymphoma cells may
help in choosing the appropriate therapy, with systemic
treatment reserved for truly systemic disease. In addition a
sensitive method of detection of minimal disease in
peripheral blood and bone marrow may have an important
role in bone marrow transplantation, particularly if
autologous marrow is used.
The search for circulating lymphoma cells by DNA hybrid-
isation cannot at present be considered part of the routinie
assessment of lymphoma patients. The exact role of this
investigation remains to be defined and so far it is too
unwieldy for regular clinical application. However, the
prospect of observing tumour cells with such precision and
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sensitivity has opened up exciting possibilities for our
understanding of the biology of lymphoma.
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